.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Citi
Mallinckrodt
Express Scripts
Medtronic
Daiichi Sankyo
Boehringer Ingelheim
Covington
Cipla

Generated: December 13, 2017

DrugPatentWatch Database Preview

SKLICE Drug Profile

« Back to Dashboard

When do Sklice patents expire, and what generic alternatives are available?

Sklice is a drug marketed by Arbor Pharms Llc and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-four patent family members in twelve countries and nine supplementary protection certificates in eight countries.

The generic ingredient in SKLICE is ivermectin. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
Drug patent expirations by year for SKLICE

Pharmacology for SKLICE

Medical Subject Heading (MeSH) Categories for SKLICE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms LlcSKLICEivermectinLOTION;TOPICAL202736-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Arbor Pharms LlcSKLICEivermectinLOTION;TOPICAL202736-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Arbor Pharms LlcSKLICEivermectinLOTION;TOPICAL202736-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for SKLICE

Drugname Dosage Strength RLD Submissiondate
ivermectinLotion0.5%Sklice9/1/2017

International Patent Family for Tradename: SKLICE

Country Document Number Estimated Expiration
Canada2666365► Subscribe
Australia2009308922► Subscribe
Japan2012507545► Subscribe
South Korea20110101138► Subscribe
Canada2741886► Subscribe
World Intellectual Property Organization (WIPO)2008067054► Subscribe
Japan5694944► Subscribe
Mexico2011004442► Subscribe
Hong Kong1133991► Subscribe
Australia2016201858► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SKLICE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0069France► SubscribePRODUCT NAME: IVERMECTINE; NAT. REGISTRATION NO/DATE: NL 44511 20150721; FIRST REGISTRATION: MT - MA 117/01101 20150402
915Luxembourg► SubscribePRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402
/2015Austria► SubscribePRODUCT NAME: IVERMECTIN; NAT. REGISTRATION NO/DATE: 136170 20150602; FIRST REGISTRATION: MT MA 117/01101 20150402
2015 00045Denmark► SubscribePRODUCT NAME: IVERMECTIN, 22, 23-DIHYDROAVERMECTINB1A + 22,23-DIHRODROAVERMECTIN B1B FOR USE IN THE TREATMNET OF RESACEA; NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402
15/046Ireland► SubscribePRODUCT NAME: IVERMECTIN; NAT REGISTRATION NO/DATE: PA0590/028/001 20150424; FIRST REGISTRATION NO/DATE: MA117/01101 20150402
2015000079Germany► SubscribePRODUCT NAME: IVERMECTIN ZU SEINER VERWENDUNG FUER DIE BEHANDLUNG VON ROSAZEA; NAT. REGISTRATION NO/DATE: 92429.00.00 20150429; FIRST REGISTRATION: MALTA MA 117/01101 20150402
0756Netherlands► SubscribePRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN DE BEHANDELING VAN ROSACEA; FIRST REGISTRATION NO/DATE: MA117/01101 20150402; NATIONAL REGISTRATION NO/DATE: RVG 115310 20150504
2015033Lithuania► SubscribePRODUCT NAME: IVERMECTINUM; NAT. REGISTRATION NO/DATE: LT/1/15/3726/001 - LT/1/15/3726/005 20150513; FIRST REGISTRATION: MA117/01101 20150402
00756Netherlands► SubscribePRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
US Department of Justice
Teva
Citi
Harvard Business School
Dow
Accenture
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot